Radioiodine remnant ablation in low‐risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|4|7|1031-1038

ISSN: 2045-7634

Source: Cancer Medicine, Vol.4, Iss.7, 2015-07, pp. : 1031-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content